← All trials
NCT03246230
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 6, 2017
- Primary completion
- Aug 20, 2019
- Completion date
- Aug 20, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 720
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Harvard UniversityLead sponsor
- Harvard UniversityOverall official - principal investigator
- Harvard UniversityReponsible party - principal investigator
- Medical Research Council, The GambiaStudy chair
- Medical Research Council, The GambiaCollaborator
- University of Western AustraliaCollaborator
- University of Western AustraliaStudy director
- University of British ColumbiaCollaborator
- Harvard UniversitySponsor investigator
- University of Western AustraliaOfficial
- Medical Research Council, The GambiaOfficial
- Harvard UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.